423 related articles for article (PubMed ID: 25143957)
1. HLA-G as a tolerogenic molecule in transplantation and pregnancy.
Rebmann V; da Silva Nardi F; Wagner B; Horn PA
J Immunol Res; 2014; 2014():297073. PubMed ID: 25143957
[TBL] [Abstract][Full Text] [Related]
2. HLA-G and humanized mouse models as a novel therapeutic approach in transplantation.
Ajith A; Portik-Dobos V; Horuzsko DD; Kapoor R; Mulloy LL; Horuzsko A
Hum Immunol; 2020 Apr; 81(4):178-185. PubMed ID: 32093884
[TBL] [Abstract][Full Text] [Related]
3. [HLA-G: from feto-maternal tolerance to organ acceptance].
Carosella ED
Bull Acad Natl Med; 2014; 198(4-5):801-11; discussion 812. PubMed ID: 26753410
[TBL] [Abstract][Full Text] [Related]
4. New insights into HLA-G mediated tolerance.
Amodio G; Sales de Albuquerque R; Gregori S
Tissue Antigens; 2014 Sep; 84(3):255-63. PubMed ID: 25132109
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressive molecule HLA-G and its clinical implications.
González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation.
Rouas-Freiss N; Naji A; Durrbach A; Carosella ED
Transplantation; 2007 Jul; 84(1 Suppl):S21-5. PubMed ID: 17632407
[TBL] [Abstract][Full Text] [Related]
7. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
[TBL] [Abstract][Full Text] [Related]
8. Mouse models for studies of HLA-G functions in basic science and pre-clinical research.
Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Mulloy LL; Horuzsko A
Hum Immunol; 2016 Sep; 77(9):711-9. PubMed ID: 27085792
[TBL] [Abstract][Full Text] [Related]
9. Tolerization of dendritic cells by HLA-G.
Ristich V; Liang S; Zhang W; Wu J; Horuzsko A
Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701
[TBL] [Abstract][Full Text] [Related]
10. 10-Year Experience with HLA-G in Heart Transplantation.
Lazarte J; Adamson MB; Tumiati LC; Delgado DH
Hum Immunol; 2018 Aug; 79(8):587-593. PubMed ID: 29859206
[TBL] [Abstract][Full Text] [Related]
11. Role of the HLA-G immune checkpoint molecule in pregnancy.
Rouas-Freiss N; Moreau P; LeMaoult J; Papp B; Tronik-Le Roux D; Carosella ED
Hum Immunol; 2021 May; 82(5):353-361. PubMed ID: 33745758
[TBL] [Abstract][Full Text] [Related]
12. HLA-G14bp ins/del polymorphism and post-transplant weight gain in kidney transplantation: potential implications beyond tolerance.
Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; Clemente K; Iesari S; Lai Q; Pisani F
BMC Nephrol; 2020 Mar; 21(1):109. PubMed ID: 32228494
[TBL] [Abstract][Full Text] [Related]
13. The dual role of HLA-G in cancer.
Rouas-Freiss N; Moreau P; LeMaoult J; Carosella ED
J Immunol Res; 2014; 2014():359748. PubMed ID: 24800261
[TBL] [Abstract][Full Text] [Related]
14. HLA-G: At the Interface of Maternal-Fetal Tolerance.
Ferreira LMR; Meissner TB; Tilburgs T; Strominger JL
Trends Immunol; 2017 Apr; 38(4):272-286. PubMed ID: 28279591
[TBL] [Abstract][Full Text] [Related]
15. HLA and pregnancy: the paradox of the fetal allograft.
Ober C
Am J Hum Genet; 1998 Jan; 62(1):1-5. PubMed ID: 9443885
[No Abstract] [Full Text] [Related]
16. HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
[TBL] [Abstract][Full Text] [Related]
17. Immunotolerant functions of HLA-G.
Carosella ED; Dausset J; Rouas-Freiss N
Cell Mol Life Sci; 1999 Mar; 55(3):327-33. PubMed ID: 10228553
[TBL] [Abstract][Full Text] [Related]
18. Biological Characteristics of HLA-G and Its Role in Solid Organ Transplantation.
Liu S; Bos NA; Verschuuren EAM; van Baarle D; Westra J
Front Immunol; 2022; 13():902093. PubMed ID: 35769475
[TBL] [Abstract][Full Text] [Related]
19. Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.
Nardi Fda S; König L; Wagner B; Giebel B; Santos Manvailer LF; Rebmann V
HLA; 2016 Sep; 88(3):77-86. PubMed ID: 27440734
[TBL] [Abstract][Full Text] [Related]
20. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
Agrawal S; Pandey MK
J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
